Presentations

      Computational Platform For Compound Identification

      Monge, A.; Cano, S.; Albrecht, S.; Pospisil, P.; Martin, E.
      Conference date
      Jun 19, 2013
      Conference name
      ACD/LABS Symposium On Laboratory Intelligence (EUM) 
      Link to more information
      Link to more information
      Topic
      Summary

      The identification of compounds from complex matrices (such as smoke aerosols or biological samples) that may contain thousands of chemical entities remains a considerable analytical challenge, even when sophisticated analytical instruments and state-of-the-art analytical data processing software are used. This is recognized to be the most challenging step in many scientific fields, including metabolomics. In order to increase the level of confidence in compound identification from smoke aerosols, and to automate a maximum number of manual steps currently performed by scientists, a set of informatics tools to build a computational platform for compound identification is being developed at Philip Morris International. The first component of this platform is a chemical and spectral registration system that enables unambiguous referencing of chemicals and their spectral data. This platform entitled ‘Unique Compound and Spectra Database (UCSD)’ was developed internally and is based upon two software systems: oracle with Accelrys direct chemical cartridge to manage chemical structures, and ACD/Labs modules Chemfolder and mass Spectra Database to record analytical spectra. The second component of the platform entitled ‘Computer-Assisted Structure Identification (CASI)’ directly supports the compound identification process and is composed of several modules, each built to support a specific analytical chemistry workflow. Such workflows include, for example, automated non-targeted screening, comparison of chemical composition for two mixtures and puff-by-puff analysis, all of which are essential for the analysis of smoke aerosol samples. Furthermore, it is planned to consolidate all analytical data within an R&D scientific analytical warehouse, which will ease the process for comparing the chemical composition of different samples and provide a central point for data reporting. The challenges and pitfalls encountered during the development of this platform will be discussed. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.